DBTX — Decibel Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall Cap
- $123.37m
- $45.17m
Annual cashflow statement for Decibel Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -36.2 | -42.7 | -39.3 | -51.8 | -63 |
| Depreciation | |||||
| Non-Cash Items | -0.435 | 0.183 | 2.78 | 3.77 | 5.26 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.957 | -8.69 | 2.25 | 3.49 | -0.618 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -36.1 | -49.4 | -32.7 | -43.1 | -56.9 |
| Capital Expenditures | -1.29 | -0.717 | -0.273 | -0.745 | -0.463 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -70.1 | 58.1 | -12.7 | -100 | 55.6 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -71.4 | 57.3 | -13 | -101 | 55.1 |
| Financing Cash Flow Items | — | — | 0.424 | -0.193 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 55.1 | -0.005 | 54.9 | 153 | -0.213 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -52.4 | 7.92 | 9.18 | 8.37 | -2.01 |